AU2024263322A1 - Compositions and methods for treating post-traumatic stress disorder - Google Patents
Compositions and methods for treating post-traumatic stress disorderInfo
- Publication number
- AU2024263322A1 AU2024263322A1 AU2024263322A AU2024263322A AU2024263322A1 AU 2024263322 A1 AU2024263322 A1 AU 2024263322A1 AU 2024263322 A AU2024263322 A AU 2024263322A AU 2024263322 A AU2024263322 A AU 2024263322A AU 2024263322 A1 AU2024263322 A1 AU 2024263322A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- stress disorder
- traumatic stress
- treating post
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363499089P | 2023-04-28 | 2023-04-28 | |
| US63/499,089 | 2023-04-28 | ||
| PCT/US2024/026542 WO2024226995A1 (en) | 2023-04-28 | 2024-04-26 | Compositions and methods for treating post-traumatic stress disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2024263322A1 true AU2024263322A1 (en) | 2025-11-13 |
Family
ID=93257132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2024263322A Pending AU2024263322A1 (en) | 2023-04-28 | 2024-04-26 | Compositions and methods for treating post-traumatic stress disorder |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2024263322A1 (en) |
| WO (1) | WO2024226995A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020258086A1 (en) * | 2019-04-17 | 2021-11-11 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| TW202304423A (en) * | 2021-04-01 | 2023-02-01 | 美商泰仁生物科學公司 | Methods and compositions relating to psychedelics and serotonin receptor modulators |
| IL309953A (en) * | 2021-07-07 | 2024-03-01 | Arcadia Medicine Inc | Psychoactive compounds are safer |
| EP4398871A1 (en) * | 2021-09-08 | 2024-07-17 | Cybin IRL Limited | Combination drug therapies |
| WO2023049480A1 (en) * | 2021-09-25 | 2023-03-30 | Alexander Shulgin Research Institute | Substituted phenylalkylamines |
| IL319372A (en) * | 2022-09-06 | 2025-05-01 | Hadasit Med Res Service | Combinations comprising psychedelics for the treatment of schizophrenia and other neuropsychiatric and neurologic disorders |
-
2024
- 2024-04-26 WO PCT/US2024/026542 patent/WO2024226995A1/en active Pending
- 2024-04-26 AU AU2024263322A patent/AU2024263322A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024226995A1 (en) | 2024-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4352079A4 (en) | Compositions and methods for treating neurofibromatic disorders | |
| EP4096675A4 (en) | Compositions and methods for treating long covid | |
| EP4340836A4 (en) | Methods and compositions for treating neurological conditions | |
| AU2021372482A9 (en) | Compositions and methods for treating hematopoietic malignancy | |
| AU2024263322A1 (en) | Compositions and methods for treating post-traumatic stress disorder | |
| CA3290472A1 (en) | Compositions and methods for treating post-traumatic stress disorder | |
| EP4157260A4 (en) | Compositions and methods for treating headaches | |
| EP4294793A4 (en) | Compositions and methods for treating tauopathies | |
| EP4175978A4 (en) | Compositions and methods for treating crp-mediated diseases | |
| EP4522159A4 (en) | Compositions and methods for treating epilepsy | |
| CA3278586A1 (en) | Compositions and methods for treating alpha-synucleinopathies | |
| AU2024322388A1 (en) | Methods and compositions for treating ctnnb1-associated disorders | |
| HK40102681A (en) | Methods and compositions for treating an angiotensinogen- (agt-) associated disorder | |
| CA3278656A1 (en) | Methods and compositions for treating hsd-1-mediated disorders | |
| AU2022903123A0 (en) | Compositions and methods for treating disorders | |
| HK40108610A (en) | Compositions and methods for treating neurofibromatic disorders | |
| CA3278829A1 (en) | Compositions and methods for treating cystitis | |
| HK40111177A (en) | Methods and compositions for treating an angiotensinogen- (agt-) associated disorder | |
| HK40107542A (en) | Methods and compositions for treating epilepsy | |
| HK40110376A (en) | Compositions and methods for treating neurofibromatic disorders | |
| HK40092865A (en) | Compositions and methods for treating epilepsy | |
| HK40092865B (en) | Compositions and methods for treating epilepsy | |
| HK40090735A (en) | Methods and compositions for treating epilepsy | |
| HK40085044A (en) | Compositions and methods for treating obsessive-compulsive disorder | |
| HK40089718A (en) | Methods and compositions for treating multiple sclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Free format text: FORMER NAME(S): YALE UNIVERSITY Owner name: YALE UNIVERSITY Free format text: FORMER NAME(S): YALE UNIVERSITY |